Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Activated charcoal forms non-IgE binding complexes with peanut proteins.

Peter Vadas1, Boris Perelman

  • 1Department of Medicine, St Michael's Hospital, University of Toronto, Ontario, Cananda.

The Journal of Allergy and Clinical Immunology
|July 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapies.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.

The Journal of allergy and clinical immunology·2026
Same author

Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis.

The World Allergy Organization journal·2026
Same author

Anaphylaxis to a blood feeding leech.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Prevalence of Autoantibodies in Patients with Hereditary Alpha-Tryptasemia.

International archives of allergy and immunology·2024
Same author

Avapritinib versus Placebo in Indolent Systemic Mastocytosis.

NEJM evidence·2024
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Activated charcoal (AC) effectively binds to peanut protein, preventing allergic reactions. This study shows AC can remove both IgE- and IgG-binding peanut proteins from solution, suggesting its potential use in managing peanut allergy.

Area of Science:

  • Allergy and Immunology
  • Gastroenterology
  • Pharmacology

Background:

  • Conventional peanut-induced anaphylaxis management focuses on immediate treatment and stabilization.
  • Preventing further gastrointestinal absorption of peanut protein is not a standard therapeutic approach.

Purpose of the Study:

  • To investigate activated charcoal's capacity to complex with peanut protein.
  • To assess if this complexation prevents peanut protein binding to IgE and IgG antibodies.

Main Methods:

  • Peanut protein was incubated with activated charcoal at varying pH levels.
  • Binding to peanut-specific IgG was measured using ELISA.
  • Binding to peanut-specific IgE was assessed via Western blot and skin prick tests.

Related Experiment Videos

Main Results:

  • Activated charcoal rapidly formed complexes with peanut protein at neutral and acidic pH.
  • Complexation effectively inhibited peanut protein binding to both IgG and IgE antibodies.
  • Complete removal of peanut protein required a 200:1 ratio of activated charcoal to protein.

Conclusions:

  • Activated charcoal efficiently removes IgE- and IgG-binding peanut proteins from solutions.
  • This suggests activated charcoal could be a valuable adjunct therapy to limit peanut protein absorption post-ingestion in allergic individuals.